Search for more clinical trials
Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)
Conditions
Esophageal Squamous Cell Carcinomas
Conditions: official terms
Carcinoma, Squamous Cell - Esophageal Neoplasms
Conditions: Keywords
Esophageal Squamous Cell carcinomas, Endoscopy Screening, High risk region, China
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening
Intervention
Name: Endoscopy Screening
Type: Procedure
Overall Status
Recruiting
Summary
The purposes of this study are as follows:
1. Establish clinical criteria of endoscopy screening on esophageal cancer in high risk region of China;
2. Evaluate the efficacy of endoscopy screening on esophageal cancer;
3. Determine the most cost-effective strategy of endoscopy screening in high risk population of China.
1. Establish clinical criteria of endoscopy screening on esophageal cancer in high risk region of China;
2. Evaluate the efficacy of endoscopy screening on esophageal cancer;
3. Determine the most cost-effective strategy of endoscopy screening in high risk population of China.
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: 69 Years
Minimum Age: 40 Years
Gender: Both
Criteria: Inclusion Criteria:
1. permanent residency in one of the 334 target villages which were randomly selected from all the 968 villages of Hua County of Anyang, China;
2. age between 40 and 69 years;
3. willingness to participate in this study and complete all parts of the examination.
Exclusion Criteria:
1. self-reported history of cancer, cardiovascular disease, mental disorder, or other contraindications for endoscopy;
2. self-reported history of infection with hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV), and any evidence of these infections based on serum screening;
3. history of endoscopy examination within 5 years prior to the interview.
1. permanent residency in one of the 334 target villages which were randomly selected from all the 968 villages of Hua County of Anyang, China;
2. age between 40 and 69 years;
3. willingness to participate in this study and complete all parts of the examination.
Exclusion Criteria:
1. self-reported history of cancer, cardiovascular disease, mental disorder, or other contraindications for endoscopy;
2. self-reported history of infection with hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV), and any evidence of these infections based on serum screening;
3. history of endoscopy examination within 5 years prior to the interview.
Location
Laboratory of Genetics, Beijing Cancer Hospital and Institute, Peking University
Beijing, Bejing, China
Status: Recruiting
Contact: Hong Cai, M.D. - 8610-88196762 - drhcai@gmail.com
Start Date
January 2012
Completion Date
December 2022
Sponsors
Peking University
Source
Peking University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page